Showing results (1681-1690 of 1,909) with videos related to

Sort By:
Pageof 191
American Journal of Infection Control|June 1, 2023
Risk factors for hospital-onset Clostridioides difficile infections before and during the severe acute respiratory syndrome coronavirus 2 pandemicJennie H Kwon, Katelin B Nickel, Kimberly A Reske, et al.
Antiviral Research|September 11, 2002
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infectionsRobert Snoeck, Graciela Andrei, Bahram Bodaghi, et al.
The Lancet. Neurology|April 1, 2014
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trialDavid Michelson, Ellen Snyder, Erin Paradis, et al.
Science Advances|March 28, 2025
Scalable fabrication of Chip-integrated 3D-nanostructured electronic devices via DNA-programmable assemblyAaron Michelson, Lior Shani, Jason S Kahn, et al.
The Journal of Hospital Infection|December 9, 2022
Risk factors for hospital-acquired infection during the SARS-CoV-2 pandemicJ H Kwon, K B Nickel, K A Reske, et al.
Journal of the Pediatric Infectious Diseases Society|December 11, 2024
Alternative Antibiotic Selections During the 2022 Amoxicillin Shortage in the United StatesSriram Ramgopal, Marc Rosenman, Lu Zhang, et al.
Psychopharmacology|March 8, 2017
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 dataW Joseph Herring, Kathryn M Connor, Ellen Snyder, et al.
Behaviour Research and Therapy|August 31, 2019
Development of a transdiagnostic, low-intensity, psychological intervention for common adolescent mental health problems in Indian secondary schoolsDaniel Michelson, Kanika Malik, Madhuri Krishna, et al.
Human Mutation|September 25, 2022
Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33AElena V Pavlova, Dorit Lev, Marina Michelson, et al.
Cephalalgia : an International Journal of Headache|May 1, 2015
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraineTony W Ho, Andrew P Ho, Yang Joy Ge, et al.
Pageof 191